Cerus Corporation logo
Cerus Corporation CERS
€ 1.83 0.0%

Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025

report update icon

Cerus Corporation DSO 2011-2025 | CERS

DSO Jährlich Cerus Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
59.2 68.3 57.7 53 60.8 65.7 42 88.3 63.8 61.8 55.1 56.4 44.2 67.3

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
88.3 42 60.3

DSO Vierteljährlich Cerus Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - - - - - - - - - - - - - - - - - 51.9 51.8 - - 105 119 - - - - - - - - - - - - - - - - - - 49.1 44 54.8 - 60.1 82.4 -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
119 44 68.7

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
31.5 $ 4.67 - $ 775 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
6.01 $ 3.36 - $ 260 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
25 - -15.15 % $ 60.3 M britainBritain
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
132 $ 210.16 - $ 5 B danmarkDanmark
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Aptorum Group Limited Aptorum Group Limited
APM
20.6 $ 1.33 - $ 7.25 M chinaChina
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.42 - $ 8.23 B australiaAustralia
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
62.6 $ 25.9 - $ 1.25 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
77.3 $ 9.49 - $ 139 M usaUSA
Brickell Biotech Brickell Biotech
BBI
254 - -5.38 % $ 6.06 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
49.5 - 0.49 % $ 251 B cayman-islandsCayman-islands
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
6.09 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
103 - -7.31 % $ 87 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
150 $ 2.28 - $ 14.3 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
946 - -6.81 % $ 3.04 B usaUSA
Biogen Biogen
BIIB
57.9 $ 172.5 - $ 25.1 B usaUSA
Baudax Bio Baudax Bio
BXRX
126 - 0.59 % $ 63 K usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
13.2 - -0.88 % $ 598 M usaUSA
Axon Enterprise Axon Enterprise
AXON
134 $ 581.03 - $ 44 B usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
164 - -16.75 % $ 25.8 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
65.5 - -7.23 % $ 13 M usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
141 $ 12.96 1.17 % $ 533 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
60.8 - - $ 2.18 B usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
169 $ 11.44 - $ 740 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
157 - -5.68 % $ 8.28 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 0.29 -0.31 % $ 631 M israelIsrael
Catalyst Biosciences Catalyst Biosciences
CBIO
3.24 $ 15.31 - $ 1.01 B usaUSA
Epizyme Epizyme
EPZM
47.2 - - $ 249 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA